Clinical Trial Update: Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE) [NA]

View source ↗

Summary

An update on the DIVERSE initiative to improve inclusivity, validity, and equity in leukemia research through strategic engagement.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Blood Cancer, Leukemia | NA | Status: RECRUITING